Health
AHA: New Medication, Finerenone, Helps Heart Health in People With Chronic Kidney Disease, Type 2 Diabetes – Cath Lab Digest
DALLAS, Nov. 17, 2020 — The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events…
DALLAS, Nov. 17, 2020 — The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events in patients with chronic kidney disease and Type 2 diabetes, according to late-breaking research presented at the American Heart Association’s Scientific Sessions 2020. The virtual meeting is Friday, November 13-Tuesday, November 17, 2020, and is a premier global exchange of the latest scientific advancements, research and evidence-based…
-
Noosa News22 hours agoTeenaged driver killed in head-on collision at Brassall in Queensland
-
Noosa News19 hours agoAustralian snow tourists bringing own meals, tents and BBQs to cut cost of ski trips
-
Noosa News21 hours agoDismayed buyers surrendering ‘teacup’ pigs weighing up to 300kg
-
Noosa News20 hours agoYoung man stabbed in the neck at Bingal Bay home in Queensland